☰
✕

Analysis of Hemolytic Properties of Nanoparticles

Link To Website Link To Webstore
Standard Number ITA-1
Organization Nanotechnology Characterization Laboratory
Level National
Category Specification
Status
  • JAN 2009 Published
  • MAY 2020 Revised
ABSTRACT
The hemolytic potential of all intravenously administered pharmaceuticals must be evaluated. Hemolysis (destruction of red blood cells) in vivo can lead to anemia, jaundice and other pathological conditions.